AI assistant
Cipla Ltd. — Board/Management Information 2025
Jun 1, 2025
59275_rns_2025-06-01_40819c78-0b27-41f7-9328-6efc54d1894a.pdf
Board/Management Information
Open in viewerOpens in your device viewer

1st June, 2025
- Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor Dalal Street Plot no. C/1, G Block
- (3) SOCIETE DE LA BOURSE DE Luxemberg Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg
Sub: Change in Senior Management Personnel
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Board of Directors of the Company have appointed Mr Prabhakaran Balakrishnan Nair, presently working as Chief of Quality – Indore plant, as Senior Management Personnel and Global Chief Manufacturing Officer of the Company w.e.f. 1st July, 2025.
The details required to be disclosed under the SEBI Listing Regulations read with SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 on the captioned subject are enclosed to this letter as 'Annexure A'.
Kindly take the above information on record.
Thanking you,
Yours faithfully,
For Cipla Limited Rajendra Chopra RAJENDR A KUMAR CHOPRA Digitally signed by RAJENDRA KUMAR CHOPRA Date: 2025.06.01 18:30:19 +05'30'
Company Secretary
Encl: a/a
Prepared by: Mandar Kurghode
Cipla Ltd.
(1) BSE Limited (2) National Stock Exchange of India Limited Mumbai 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA

Annexure A
Details as per SEBI circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024
| Name | Mr Prabhakaran Balakrishnan Nair |
|---|---|
| Reasonforchangeviz. | Appointment of Mr Prabhakaran Balakrishnan Nair, as Senior Management |
| appointment, resignation, | Personnel designated as Global Chief Manufacturing Officer of the Company |
| removal,deathor | w.e.f. 1st July, 2025. |
| otherwise | |
| Date of Appointment/re | 1st July, 2025 |
| appointment/cessation | |
| andtermsof | Terms of appointment: Full-time employment |
| appointment/re | |
| appointment | |
| Brief Profile (in case of | Mr. Prabhakaran Balakrishnan Nair is a seasoned leader with over thirty-four |
| appointment) | years of extensive experience in manufacturing operations and quality |
| management within the pharmaceutical industry. | |
| Prior to joining Cipla, Prabhakaran was the Chief Operating Officer at Encube | |
| Ethicals, India. In this role, he was responsible for scaling up operations and | |
| product lines for the company including spearheading greenfield expansions | |
| for two sites at Goa and Indore. | |
| Prior to this, he has held leadership roles at ACG Worldwide, Dr. Reddy's | |
| Laboratories, IPCA Laboratories and Cadila Pharmaceuticals. | |
| At Cipla, Prabhakaran is a Cluster Head in the Quality function and a member | |
| of the Cipla Leadership Group. He has been instrumental in fostering a strong | |
| quality culture through robust assurance frameworks and regulatory | |
| compliance initiatives. His expertise has strengthened the Global Quality | |
| Function through enhancing regulatory audit preparedness and integrating | |
| AI-driventechnologicaladvancementsintoqualityoperations.His | |
| leadership, combined with deep domain expertise in both manufacturing and | |
| quality, has helped sustain regulatory compliance, foster cross-functional | |
| collaborations, and drive superior value creation. | |
| He holds a Master of Business Administration degree from Mumbai | |
| University (1992) and a Master of Pharmacy degree from Mumbai University | |
| (1988). | |
| Disclosure of relationship | Not applicable. |
| between directors | |
| (in case of appointment of | |
| a director) |
Cipla Ltd.